tetano
Editor, Senior Moderator
Pediatr Infect Dis J. 2020 Feb;39(2):e20-e22. doi: 10.1097/INF.0000000000002528. [h=1]Early Administration of Oseltamivir Within 48 Hours After Onset of Flulike Symptoms Can Reduce the Risk of Influenza B Virus-Associated Pneumonia in Hospitalized Pediatric Patients with Influenza B Virus Infection.[/h]
Dai Z[SUP]1[/SUP], Zhang L, Yu Q, Liu L, Yang M, Fan K.
[h=3]Author information[/h]
[h=3]Abstract[/h] We conducted a retrospective study to identify the risk factors for pneumonia in hospitalized pediatric patients with influenza B infection. Receiving oseltamivir within the first 48 hours of onset and frequent cough was respectively considered as a protective factor and a risk factor for the influenza B virus-associated pneumonia in hospitalized pediatric patients. Early administration of oseltamivir can reduce the risk of influenza B virus-associated pneumonia.
PMID: 31929434 DOI: 10.1097/INF.0000000000002528
Dai Z[SUP]1[/SUP], Zhang L, Yu Q, Liu L, Yang M, Fan K.
[h=3]Author information[/h]
[h=3]Abstract[/h] We conducted a retrospective study to identify the risk factors for pneumonia in hospitalized pediatric patients with influenza B infection. Receiving oseltamivir within the first 48 hours of onset and frequent cough was respectively considered as a protective factor and a risk factor for the influenza B virus-associated pneumonia in hospitalized pediatric patients. Early administration of oseltamivir can reduce the risk of influenza B virus-associated pneumonia.
PMID: 31929434 DOI: 10.1097/INF.0000000000002528